Serum lipid values → Atherosclerosis | Peripheral arterial disease (PAD)
◼Hyperlipidemia (↑LDL 175, ↓HDL 30, ↑Total Chol 250) accelerates atherosclerotic plaque formation within medium–large arteries, the pathologic basis of PAD.
◼LDL infiltration into the intima triggers oxidation and macrophage uptake, forming foam cells and fatty streaks, which mature into fibroatheromas that narrow arterial lumen.
◼Low HDL reduces reverse cholesterol transport, diminishing the body’s ability to clear arterial cholesterol, thereby promoting plaque growth.
◼Systemic atherosclerosis explains multisite arterial insufficiency (e.g., coronary disease + limb ischemia), consistent with claudication here.
◼ Lipid control (diet, statins, lifestyle) reduces MACE (major adverse cardiovascular events) and limb ischemia progression.
Pressure injury/ulcer location → Chronic venous insufficiency (CVI) | PAD
◼ CVI ulcers typically occur at the medial malleolus/ankle due to venous hypertension, valve reflux, and tissue edema causing shallow, exudative wounds with irregular borders.
◼ PAD ulcers occur at distal pressure points—toes, lateral foot, bony prominences—from critical ischemia; they’re often “punched-out,” dry, painful, and slow to heal.
◼ This client’s ulcer on the tip of the great toe plus rest pain and relief in dependency aligns with arterial insufficiency, supporting PAD.
◼ Ulcer location is a high-yield anatomical clue that helps differentiate venous (ankle/medial) from arterial (toe/distal) disease for targeted management.
◼ Correct classification drives care (e.g., compression for CVI vs perfusion/revascularization for PAD).
Skin on the right leg → CVI | PAD
◼ PAD skin changes: Shiny, dry, hairless skin, pallor on elevation, dependent rubor, cool temperature—all reflect chronic tissue hypoperfusion and autonomic tone shifts.
◼ These match the client’s shiny, hair-sparse, color-changing leg.
◼ CVI skin changes: Brown hyperpigmentation (hemosiderin), thickened/woody edema, varicosities, and stasis dermatitis from venous hypertension and RBC leakage into tissues.
◼ The client’s dependent hyperpigmentation can be seen in venous disease, but the pallor on elevation and trophic changes (shiny, hair loss, dry) are more specific for PAD.
◼ Recognizing these contrasting cutaneous patterns prevents mismanagement (e.g., inappropriate compression in severely ischemic limbs).
◼ Documenting temperature, capillary refill, color with position, hair distribution supports trend monitoring and vascular referral.
Pedal pulses → Atherosclerosis | PAD
◼ Diminished right pedal pulse (1+) versus left (2+) signals asymmetric arterial flow, consistent with focal atherosclerotic stenosis in lower-extremity arteries (e.g., SFA, popliteal).
◼ Atherosclerotic narrowing reduces distal pulse amplitude, especially with exercise-induced flow demands, explaining intermittent claudication and rest pain in advanced disease.
◼ Pulse asymmetry warrants objective testing (e.g., ABI ≤0.90, segmental pressures, duplex ultrasound) to stage PAD and guide revascularization decisions.
◼ Weak pulses correlate with poor wound healing (e.g., the client’s toe ulcer) and limb threat if critical limb ischemia evolves.
◼ Addressing upstream risk factors (smoking cessation, statins, antiplatelets, BP control) improves limb and cardiovascular outcomes.